Last edition
News about "Sentynl Therapeutics"
Sentynl and Mereo Partner on Alvelestat for AATD-Associated Lung Disease
Sentynl Therapeutics and Mereo BioPharma have signed an option and license deal for alvelestat, with Sentynl set to commercialise it in the US upon option exercise.
Sentynl Therapeutics | 12/08/2026 | By News Bureau
Sentynl Therapeutics Completes Acquisition of Eiger BioPharmaceuticals' Zokinvy Program
Zokinvy is the first and only treatment approved by the US Food and Drug Administration (FDA) for Hutchinson-Gilford progeria syndrome (HGPS) and processing-deficient progeroid laminopathies (PDPL).
Sentynl Therapeutics | 04/05/2024 | By Abha | 1164
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy